Potential Therapeutic Initiatives for Fibrogenic Lung Diseases

This publication has 84 references indexed in Scilit:

• Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis
  Human Gene Therapy, 1993
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
  Nature, 1992
• Inhibitory Action of Tetrandrine on Macrophage Production of Interleukin-1 (IL-l)-Like Activity and Thymocyte Proliferation
  Experimental Lung Research, 1992
• Locally applied GM-CSF induces the accumulation of α-smooth muscle act in containing myofibroblasts
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1991
• Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
  Thorax, 1989
• Treatment of experimental silicosis with antifibrotic agents
  Toxicology, 1988
• Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor.
  Journal of Clinical Investigation, 1988
• PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts
  Biochemical and Biophysical Research Communications, 1987
• Effect of Taurine on ⁴⁵Ca²⁺ Accumulation in Rat Brain Synaptosomes
  Journal of Neurochemistry, 1980
• The effect of taurine on calcium exchange of sarcoplasmic reticulum of guinea pig heart studied by means of dialysis kinetics
  Canadian Journal of Physiology and Pharmacology, 1976